Drugs / HBN-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04094857 | Oct 2019 → Nov 2020 | cardiac arrest | Hibernaid, Inc | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HBN-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04094857 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT04094857 ↗ |